What Does Wall Street Think About Pharvaris N.V. (PHVS)?
Pharvaris N.V. (NASDAQ:PHVS) is one of the best small cap stocks to buy with huge upside potential. Morgan Stanley analyst Maxwell Skor reiterated a Buy rating on Pharvaris N.V.
Pharvaris N.v. (PHVS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Viking Global Andreas Halvorsen | 3,653,310 | $103,206,008 | 0.29% | |
| 2. | Deerfield Management James E. Flynn | 3,126,042 | $88,310,687 | 1.04% | |
| 3. | Commodore Capital Egen Atkinson And Michael Kramarz | 1,918,970 | $54,210,903 | +2% | 3.14% |
| 4. | Saturn V Capital Management Xiaoying Tian | 1,201,402 | $33,939,606 | +6% | 6.15% |
| 5. | Point72 Asset Management Steve Cohen | 1,007,016 | $28,448,202 | +42% | 0.04% |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $35.49 | 30,712 | $1,090,048.73 | 315,167 | 2026-06-30 | Filing | |
| $35.05 | 6,888 | $241,447.13 | 345,879 | 2026-06-29 | Filing | |
| $35.49 | 30,703 | $1,089,637.19 | 93,969 | 2026-06-30 | Filing | |
| $35.05 | 6,997 | $245,231.56 | 124,672 | 2026-06-29 | Filing | |
| $35.48 | 27,872 | $988,890.20 | 58,750 | 2026-06-30 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,031,252 | $226,882,869 | 10.56% | |
| 2. | 6,284,472 | $177,536,335 | 0.01% | |
| 3. | 4,778,581 | $134,994,913 | 56.94% | |
| 4. | 4,639,304 | $131,060,338 | 46.71% | |
| 5. | 3,424,609 | $96,745,204 | 9.48% |
News See All
12 Small Cap Stocks to Buy with Huge Upside Potential
Talking about rotation in the market, she expects the trend to continue for a while, with the capital basically moving from the high multiple mega cap winners towards small caps, cyclicals, and the international...
Why Pharvaris (PHVS) Is Advancing Today
Pharvaris (PHVS) is climbing 3% after investment bank JMP Securities raised its price target on the shares to $55, based on its optimism about the company's prophylactic treatment for Hereditary Angioedema...
Billionaire Andreas Halvorsen's Top 15 Long-Term Stock Picks
Andreas Halvorsen is a prominent Norwegian hedge fund manager and the co-founder of Viking Global, one of the most successful equity-focused hedge funds in the world.
7 Best Stocks Under $20 According to Billionaire Andreas Halvorsen's Viking Global
In this article, we take a look at the 7 best stocks under $20 according to billionaire Andreas Halvorsen's Viking Global.
Hedge Fund Resource Center